Hyungtai Sim

Hyungtai Sim

Auto-generated profile, based on publicly available information

Hyungtai Sim

Department of Biomedical Sciences, Seoul National University College of Medicine

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2022 in Gut and Liver
Verified
Journal Article
Open access
PDF file
HLHyun Woo Lee
Hyun Woo Lee
GCGoh Eun Chung
Goh Eun Chung
BKBo Kyung Koo
Bo Kyung Koo
HSHyungtai Sim
Hyungtai Sim
MCMurim Choi
Murim Choi
TCthe Innovative Target Exploration of NAFLD (ITEN) consortium
the Innovative Target Exploration of NAFLD (ITEN) consortium
Hyun Woo Lee, Goh Eun Chung, Bo Kyung Koo, Hyungtai Sim, Murim Choi, Dong Hyeon Lee, Seung Ho Choi, Soo Heon Kwak, Deog Kyeom Kim, and Won Kim, on behalf of the Innovative Target Exploration of NAFLD (ITEN) consortium. Gut and Liver 2023;17:139-49. https://doi.org/10.5009/gnl210545

20 May 2019 in Cell Biology and Toxicology
Verified
Journal Article
Open access
PDF file
WSWoo-Cheol Sim
Woo-Cheol Sim
DKDong Gwang Kim
Dong Gwang Kim
WLWonseok Lee
Wonseok Lee
HSHyungtai Sim
Hyungtai Sim
YCYou-Jin Choi
You-Jin Choi
BLByung-Hoon Lee
Byung-Hoon Lee
The original version of this article unfortunately contained a mistake in the article title.

24 February 2025 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
HMHyunchae Moon
Hyunchae Moon
MKMinsoo Kim
Minsoo Kim
HSHyungtai Sim
Hyungtai Sim
SHSungjoon Hong
Sungjoon Hong
HJHyoungseok Jeon
Hyoungseok Jeon
MCMurim Choi
Murim Choi
Brightness, pore size, wrinkles, color, elasticity, moisture, transepidermal water loss, pH, and sebum are traits that directly affect skin health and aesthetics, which vary substantially among ethnic groups and individuals. Although a complex combination of genetic and environmental factors influences these traits, an accurate estimation of skin phenotypic determination in individuals from Asian countries remains to be determined. In this study, we established the ASTAGR (Asian Skin Traits and Genetics Research) cohort, comprising 2762 female participants from 4 Asian countries (Korea, Vietnam, Thailand, and Indonesia). We documented 26 skin traits and conducted extensive skin-related surveys among the participants. Estimation of the quantitative contribution from whole-genome sequencing-based genotyping, combined with the survey findings, led to a comprehensive documentation of skin trait determination and its variation by country. This approach also revealed major variables affecting each skin trait. Our transethnic GWAS revealed 10 significant associations, 5 of which, to our knowledge, have not been previously reported. This study provides a comprehensive profile of skin traits and their regulation in the 4 Asian countries.

6 December 2024 in eLife
Verified
Journal Article
Open access
HSHyungtai Sim
Hyungtai Sim
HPHyun Jung Park
Hyun Jung Park
GPGeun-Ho Park
Geun-Ho Park
YKYeon Jeong Kim
Yeon Jeong Kim
WPWoong-Yang Park
Woong-Yang Park
MCMurim Choi
Murim Choi
Clonal hematopoiesis of indeterminate potential (CHIP) allows estimation of clonal dynamics and documentation of somatic mutations in the hematopoietic system. Recent studies utilizing large cohorts of the general population and patients have revealed significant associations of CHIP burden with age and disease status, including in cancer and chronic diseases. An increasing number of cancer patients are treated with immune checkpoint inhibitors (ICIs), but the association of ICI response in non-small cell lung cancer (NSCLC) patients with CHIP burden remains to be determined. We collected blood samples from 100 metastatic NSCLC patients before and after ICI for high-depth sequencing of the CHIP panel and 63 samples for blood single-cell RNA sequencing. Whole exome sequencing was performed in an independent replication cohort of 180 patients. The impact of CHIP status on the immunotherapy response was not significant. However, metastatic lung cancer patients showed higher CHIP prevalence (44/100 for patients vs. 5/42 for controls; p = 0.01). In addition, lung squamous cell carcinoma (LUSC) patients showed increased burden of larger clones compared to lung adenocarcinoma (LUAD) patients (8/43 for LUSC vs. 2/50 for LUAD; p = 0.04). Furthermore, single-cell RNA-seq analysis of the matched patients showed significant enrichment of inflammatory pathways mediated by NF-κB in myeloid clusters of the severe CHIP group. Our findings suggest minimal involvement of CHIP mutation and clonal dynamics during immunotherapy but a possible role of CHIP as an indicator of immunologic response in NSCLC patients.